Motion mitigation for lung cancer patients treated with active scanning proton therapy. Issue 5 (21st April 2015)
- Record Type:
- Journal Article
- Title:
- Motion mitigation for lung cancer patients treated with active scanning proton therapy. Issue 5 (21st April 2015)
- Main Title:
- Motion mitigation for lung cancer patients treated with active scanning proton therapy
- Authors:
- Grassberger, Clemens
Dowdell, Stephen
Sharp, Greg
Paganetti, Harald - Abstract:
- Abstract : Purpose: Motion interplay can affect the tumor dose in scanned proton beam therapy. This study assesses the ability of rescanning and gating to mitigate interplay effects during lung treatments. Methods: The treatments of five lung cancer patients [48 Gy(RBE)/4 fx ] with varying tumor size (21.1–82.3 cm 3 ) and motion amplitude (2.9–30.6 mm) were simulated employing 4D Monte Carlo. The authors investigated two spot sizes ( σ ∼ 12 and ∼3 mm), three rescanning techniques (layered, volumetric, breath‐sampled volumetric) and respiratory gating with a 30% duty cycle. Results: For 4/5 patients, layered rescanning 6/2 times (for the small/large spot size) maintains equivalent uniform dose within the target >98% for a single fraction. Breath sampling the timing of rescanning is ∼2 times more effective than the same number of continuous rescans. Volumetric rescanning is sensitive to synchronization effects, which was observed in 3/5 patients, though not for layered rescanning. For the large spot size, rescanning compared favorably with gating in terms of time requirements, i.e., 2 x ‐rescanning is on average a factor ∼2.6 faster than gating for this scenario. For the small spot size however, 6 x ‐rescanning takes on average 65% longer compared to gating. Rescanning has no effect on normal lung V 20 and mean lung dose (MLD), though it reduces the maximum lung dose by on average 6.9 ± 2.4/16.7 ± 12.2 Gy(RBE) for the large and small spot sizes, respectively. Gating leads to aAbstract : Purpose: Motion interplay can affect the tumor dose in scanned proton beam therapy. This study assesses the ability of rescanning and gating to mitigate interplay effects during lung treatments. Methods: The treatments of five lung cancer patients [48 Gy(RBE)/4 fx ] with varying tumor size (21.1–82.3 cm 3 ) and motion amplitude (2.9–30.6 mm) were simulated employing 4D Monte Carlo. The authors investigated two spot sizes ( σ ∼ 12 and ∼3 mm), three rescanning techniques (layered, volumetric, breath‐sampled volumetric) and respiratory gating with a 30% duty cycle. Results: For 4/5 patients, layered rescanning 6/2 times (for the small/large spot size) maintains equivalent uniform dose within the target >98% for a single fraction. Breath sampling the timing of rescanning is ∼2 times more effective than the same number of continuous rescans. Volumetric rescanning is sensitive to synchronization effects, which was observed in 3/5 patients, though not for layered rescanning. For the large spot size, rescanning compared favorably with gating in terms of time requirements, i.e., 2 x ‐rescanning is on average a factor ∼2.6 faster than gating for this scenario. For the small spot size however, 6 x ‐rescanning takes on average 65% longer compared to gating. Rescanning has no effect on normal lung V 20 and mean lung dose (MLD), though it reduces the maximum lung dose by on average 6.9 ± 2.4/16.7 ± 12.2 Gy(RBE) for the large and small spot sizes, respectively. Gating leads to a similar reduction in maximum dose and additionally reduces V 20 and MLD. Breath‐sampled rescanning is most successful in reducing the maximum dose to the normal lung. Conclusions: Both rescanning (2–6 times, depending on the beam size) as well as gating was able to mitigate interplay effects in the target for 4/5 patients studied. Layered rescanning is superior to volumetric rescanning, as the latter suffers from synchronization effects in 3/5 patients studied. Gating minimizes the irradiated volume of normal lung more efficiently, while breath‐sampled rescanning is superior in reducing maximum doses to organs at risk. … (more)
- Is Part Of:
- Medical physics. Volume 42:Issue 5(2015)
- Journal:
- Medical physics
- Issue:
- Volume 42:Issue 5(2015)
- Issue Display:
- Volume 42, Issue 5 (2015)
- Year:
- 2015
- Volume:
- 42
- Issue:
- 5
- Issue Sort Value:
- 2015-0042-0005-0000
- Page Start:
- 2462
- Page End:
- 2469
- Publication Date:
- 2015-04-21
- Subjects:
- biological effects of ionising particles -- cancer -- dosimetry -- lung -- Monte Carlo methods -- motion compensation -- motion control -- pneumodynamics -- radiation therapy -- tumours
Monte Carlo methods -- Dosimetry/exposure assessment -- Therapeutic applications, including brachytherapy -- Conformal radiation treatment -- Pneumodyamics, respiration
Radiation therapy -- Analysis of motion -- Scintigraphy
lung cancer -- motion mitigation -- active scanning proton therapy -- interplay effect
Lungs -- Cancer -- Dosimetry -- Protons -- Proton therapy -- Statistical analysis -- Monte Carlo methods -- Tissues -- Drug delivery
Medical physics -- Periodicals
Medical physics
Geneeskunde
Natuurkunde
Toepassingen
Biophysics
Periodicals
Periodicals
Electronic journals
610.153 - Journal URLs:
- http://scitation.aip.org/content/aapm/journal/medphys ↗
https://aapm.onlinelibrary.wiley.com/journal/24734209 ↗
http://www.aip.org/ ↗ - DOI:
- 10.1118/1.4916662 ↗
- Languages:
- English
- ISSNs:
- 0094-2405
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5531.130000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 9314.xml